Advanced search
Publication Cover
OncoImmunology Volume 12, 2023 - Issue 1
Submit an article Journal homepage
2,522
Views
1
CrossRef citations to date
0
Altmetric
Original Research

BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitro

Gloria Estesoa Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, SpainView further author information
,
María José Felgueresa Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, SpainView further author information
,
Álvaro F. García-Jiméneza Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, SpainView further author information
,
Christina Reyburn-Valésa Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, SpainView further author information
,
Alberto Benguríab Servicio de Genómica, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, SpainView further author information
,
Enrique Vázquezb Servicio de Genómica, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, SpainView further author information
,
Hugh T. Reyburna Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, SpainView further author information
,
Nacho Aguilóc Grupo de Genética de Micobacterias, Departamento de Microbiología y Medicina Preventiva, Facultad de Medicina, Universidad de Zaragoza, IIS-Aragon; Zaragoza, Spain and CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III; Madrid, SpainView further author information
,
Carlos Martínc Grupo de Genética de Micobacterias, Departamento de Microbiología y Medicina Preventiva, Facultad de Medicina, Universidad de Zaragoza, IIS-Aragon; Zaragoza, Spain and CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III; Madrid, Spain;d Servicio de Microbiología, Hospital Universitario Miguel Servet, IIS Aragon; Zaragoza, SpainView further author information
,
Eugenia Puentese Clinical Research Department y Research & Development Department, Biofabri, Grupo Zendal, O’Porriño, Pontevedra, SpainView further author information
,
Ingrid Murilloe Clinical Research Department y Research & Development Department, Biofabri, Grupo Zendal, O’Porriño, Pontevedra, SpainView further author information
,
Esteban Rodrígueze Clinical Research Department y Research & Development Department, Biofabri, Grupo Zendal, O’Porriño, Pontevedra, SpainView further author information
&
Mar Valés-Gómeza Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, Madrid, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7424-3206View further author information
ORCID Icon show all
Article: 2160094 | Received 07 Sep 2022, Accepted 14 Dec 2022, Published online: 22 Dec 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.